These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38857696)

  • 1. Methionine oxidation of clusterin in Alzheimer's disease and its effect on clusterin's binding to beta-amyloid.
    Smith AS; Subramanian J; Doderer J; Moskovitz J
    Neurosci Lett; 2024 Jul; 836():137874. PubMed ID: 38857696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
    Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
    Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.
    Qi XM; Wang C; Chu XK; Li G; Ma JF
    BMC Neurosci; 2018 Jan; 19(1):2. PubMed ID: 29370749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies.
    Foster EM; Dangla-Valls A; Lovestone S; Ribe EM; Buckley NJ
    Front Neurosci; 2019; 13():164. PubMed ID: 30872998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
    Miners JS; Clarke P; Love S
    Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin in Alzheimer's disease.
    Wu ZC; Yu JT; Li Y; Tan L
    Adv Clin Chem; 2012; 56():155-73. PubMed ID: 22397031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin contributes to early stage of Alzheimer's disease pathogenesis.
    Oh SB; Kim MS; Park S; Son H; Kim SY; Kim MS; Jo DG; Tak E; Lee JY
    Brain Pathol; 2019 Mar; 29(2):217-231. PubMed ID: 30295351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine sulfoxide reductase A affects β-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease.
    Moskovitz J; Du F; Bowman CF; Yan SS
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E388-93. PubMed ID: 26786779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.
    Li X; Ma Y; Wei X; Li Y; Wu H; Zhuang J; Zhao Z
    Neurosci Bull; 2014 Feb; 30(1):162-8. PubMed ID: 24353014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology.
    Shepherd CE; Affleck AJ; Bahar AY; Carew-Jones F; Halliday GM
    Neurobiol Aging; 2020 May; 89():129-131. PubMed ID: 31813628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.
    Zhou J; Singh N; Galske J; Hudobenko J; Hu X; Yan R
    Mol Neurodegener; 2023 May; 18(1):31. PubMed ID: 37143090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin is a Potential Therapeutic Target in Alzheimer's Disease.
    Palihati N; Tang Y; Yin Y; Yu D; Liu G; Quan Z; Ni J; Yan Y; Qing H
    Mol Neurobiol; 2024 Jul; 61(7):3836-3850. PubMed ID: 38017342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin: a forgotten player in Alzheimer's disease.
    Nuutinen T; Suuronen T; Kauppinen A; Salminen A
    Brain Res Rev; 2009 Oct; 61(2):89-104. PubMed ID: 19651157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease.
    Chen P; Wang C; Ma X; Zhang Y; Liu Q; Qiu S; Liu Q; Tian J; Ni J
    PLoS One; 2013; 8(6):e66384. PubMed ID: 23805218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte-derived clusterin suppresses amyloid formation in vivo.
    Wojtas AM; Sens JP; Kang SS; Baker KE; Berry TJ; Kurti A; Daughrity L; Jansen-West KR; Dickson DW; Petrucelli L; Bu G; Liu CC; Fryer JD
    Mol Neurodegener; 2020 Nov; 15(1):71. PubMed ID: 33246484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo.
    Moskovitz J; Maiti P; Lopes DH; Oien DB; Attar A; Liu T; Mittal S; Hayes J; Bitan G
    Biochemistry; 2011 Dec; 50(49):10687-97. PubMed ID: 22059533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation.
    Hou L; Lee HG; Han F; Tedesco JM; Perry G; Smith MA; Zagorski MG
    J Alzheimers Dis; 2013; 37(1):9-18. PubMed ID: 23719512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.